Bioventus (BVS) - 2023 Q3 - Earnings Call Presentation

Adjusted EPS Continuing Operations Operations (d) Costs incurred were the result of adopting restructuring plans to reduce headcount, reorganize management structure, and consolidate certain facilities. (h) Represents the loss on disposal of the Wound Business. 18 We present Adjusted EBITDA, Non-GAAP Gross Profit, Non-GAAP Gross Margin, Non-GAAP Operating Income, Non-GAAP Operating Expense, Non-GAAP Operating Margin, Non-GAAP R&D, Non-GAAP Net Income from continuing operations, and Non-GAAP Earnings per sha ...